A new diagnosis code, E11.A, for patients with Type 2 diabetes in remission (medicine) will be implemented on October 1, 2025, marking a significant advancement in diabetes management.
- The new code E11.A will allow health professionals to document remission (medicine) in patients with Type 2 diabetes who have maintained normal blood sugar levels for at least three months.
- This addition is part of the 2025 ICD-10 update, which introduces hundreds of new medical diagnosis codes, reflecting evolving standards in diabetes care and management.
- The introduction of E11.A emphasizes the role of lifestyle interventions, including weight loss, in achieving and maintaining remission (medicine) for Type 2 diabetes patients.
Why It Matters
This new coding system acknowledges the potential for Type 2 diabetes patients to achieve lasting remission, promoting a shift towards preventative care and lifestyle management in diabetes treatment, which can reduce reliance on medication.